WallStreetZenWallStreetZen

NASDAQ: PALI
Palisade Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Palisade Bio earnings were -$43.7M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest PALI earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$14.6M, up 38.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PALI reported annual earnings of -$16.8M, with 16.2% growth.

PALI past earnings growth

How has PALI's earnings growth performed historically?

Company
N/A
Industry
72.11%
Market
92.92%
PALI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PALI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PALI earnings history

Current Revenue
$500.0k
Current Earnings
-$43.7M
Current Profit Margin
-8,739.2%

PALI Return on Equity

Current Company
-35.6%
Current Industry
-17.8%
Current Market
37.4%
PALI's Return on Equity (-35.6%)... subscribe to Premium to read more.
High Return on Equity Performance

PALI Return on Assets

Current Company
-34%
Current Industry
-7.5%
PALI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PALI announces earnings.

PALI Return on Capital Employed

Current Company
-38.76%
Current Industry
-5.1%
PALI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PALI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PALI-$43.69M-$43.70M-71.55%$0.91
RNAC-$130.09M-$129.51MN/A-$4.94
SLGL-$16.26M-$16.34MN/A-$5.63
TRDA-$157.99M-$161.39MN/A-$3.84
BBOT-$170.77M-$171.53MN/A-$1,229.55
View Top Biotech Stocks

Palisade Bio Earnings Reports & History FAQ

What were Palisade Bio's earnings last quarter?

On PALI's earnings call on Nov 10, 2026, Palisade Bio (NASDAQ: PALI) reported Q3 2026 earnings per share (EPS) of -$0.07, up 81.58% year over year. Total PALI earnings for the quarter were -$14.62 million. In the same quarter last year, Palisade Bio's earnings per share (EPS) was -$0.38.

If you're new to stock investing, here's how to buy Palisade Bio stock.

Is Palisade Bio profitable or losing money?

As of the last Palisade Bio earnings report, Palisade Bio is currently losing money. Palisade Bio's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$43.70 million, a 289.24% increase year over year.

What was PALI's earnings growth in the past year?

As of Palisade Bio's earnings date in Nov 10, 2026, Palisade Bio's earnings has grown year over year. PALI earnings in the past year totalled -$43.70 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.